Nanalysis Scientific (TSXV:NSCI) Total Liabilities : C$28.21 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Nanalysis Scientific Total Liabilities?

Nanalysis Scientific's Total Liabilities for the quarter that ended in Mar. 2024 was C$28.21 Mil.

Nanalysis Scientific's quarterly Total Liabilities increased from Sep. 2023 (C$27.18 Mil) to Dec. 2023 (C$30.34 Mil) but then declined from Dec. 2023 (C$30.34 Mil) to Mar. 2024 (C$28.21 Mil).

Nanalysis Scientific's annual Total Liabilities increased from Dec. 2021 (C$13.83 Mil) to Dec. 2022 (C$22.33 Mil) and increased from Dec. 2022 (C$22.33 Mil) to Dec. 2023 (C$30.34 Mil).

Nanalysis Scientific Total Liabilities Historical Data

The historical data trend for Nanalysis Scientific's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanalysis Scientific Total Liabilities Chart

Nanalysis Scientific Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

3.19

9.65

13.83

22.33

30.34

Nanalysis Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															24.11	28.61	27.18	30.34	28.21

Nanalysis Scientific Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Nanalysis Scientific's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14.596	+	(14.682	+	-4.4408920985006E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	1.065	+	0)
	=	30.34

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	53.824	-	23.481
	=	30.34

Nanalysis Scientific's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	12.707	+	(14.452	+	-1.1102230246252E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	1.047	+	0)
	=	28.21

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	53.979	-	25.773
	=	28.21

Nanalysis Scientific Total Liabilities Related Terms

Thank you for viewing the detailed overview of Nanalysis Scientific's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanalysis Scientific (TSXV:NSCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Nanalysis Scientific Corp (TSXV:NSCI) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

NSCIF:USA 1N1:Germany

Address

Bay 1, 4600 5th Street NE, Calgary, AB, CAN, T2E 7C3

Website

https://www.nanalysis.com

Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company's original product, the a 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. Its operating segments are Nanalysis, RS2D, K'Prime and Corporate. Nanalysis is a patent-protected technology company that develops, manufactures, and sells compact magnetic resonance spectrometers (MR spectrometer) for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. Geographic segments of the group are the U.S., Europe, Canada, Asia and Other regions.

Executives

Michal Okoniewski

Director

Nanalysis Scientific (TSXV:NSCI) Headlines

No Headlines